Exploiting Tumor Cell Invasiveness to Construct an Isolated Niche for Postoperative Immunotherapy.
Residual tumor cells persisting in the surgical bed are the principal drivers of postoperative tumor recurrence, yet the immunosuppressive wound healing microenvironment limits immune activation and compromises antigen enrichment and cross-presentation. To address this issue, we exploited tumor cell invasiveness to con...